Genoray Co., Ltd. (KOSDAQ:122310)
South Korea · Delayed Price · Currency is KRW 4,720.00
-10.00 (-0.21%)
At close: Apr 17, 2026
Genoray Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 108,042 | 106,982 | 97,897 | 82,604 | 74,290 |
Other Revenue | -0 | -0 | -0 | -0 | -0 |
| 108,042 | 106,982 | 97,897 | 82,604 | 74,290 | |
Revenue Growth (YoY) | 0.99% | 9.28% | 18.51% | 11.19% | 20.43% |
Cost of Revenue | 66,784 | 67,678 | 60,554 | 47,497 | 43,431 |
Gross Profit | 41,258 | 39,304 | 37,343 | 35,107 | 30,859 |
Selling, General & Admin | 24,446 | 19,820 | 17,715 | 13,708 | 10,743 |
Research & Development | 12,091 | 8,881 | 4,262 | 3,513 | 2,957 |
Amortization of Goodwill & Intangibles | 2,057 | 2,445 | 1,145 | 1,111 | 1,313 |
Other Operating Expenses | 416.28 | 177.07 | 440.95 | 252.45 | 162.25 |
Operating Expenses | 41,501 | 32,795 | 24,586 | 20,189 | 15,891 |
Operating Income | -243.29 | 6,509 | 12,757 | 14,918 | 14,968 |
Interest Expense | -1,119 | -962.53 | -557.87 | -195.09 | -176.23 |
Interest & Investment Income | 599.99 | 654.58 | 817.2 | 809.69 | 234.88 |
Currency Exchange Gain (Loss) | 99.24 | 1,419 | -212.61 | 103.18 | 513.11 |
Other Non Operating Income (Expenses) | -565.68 | -77.81 | 146.16 | 54.12 | 207.16 |
EBT Excluding Unusual Items | -1,229 | 7,543 | 12,950 | 15,690 | 15,747 |
Impairment of Goodwill | - | -1,250 | - | - | - |
Gain (Loss) on Sale of Investments | 3.12 | - | - | - | - |
Gain (Loss) on Sale of Assets | 92.35 | 487.77 | 10.92 | 14.24 | 40.58 |
Asset Writedown | - | -12,769 | - | - | - |
Pretax Income | -1,133 | -5,988 | 12,961 | 15,704 | 15,787 |
Income Tax Expense | -1,762 | -3,452 | 604.64 | 1,804 | 1,464 |
Earnings From Continuing Operations | 628.48 | -2,537 | 12,356 | 13,900 | 14,323 |
Minority Interest in Earnings | 129.21 | 739.05 | 130.23 | - | - |
Net Income | 757.69 | -1,797 | 12,486 | 13,900 | 14,323 |
Net Income to Common | 757.69 | -1,797 | 12,486 | 13,900 | 14,323 |
Net Income Growth | - | - | -10.17% | -2.95% | 40.80% |
Shares Outstanding (Basic) | 12 | 13 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 12 | 13 | 14 | 14 | 14 |
Shares Change (YoY) | -6.71% | -2.80% | -2.61% | -1.59% | -0.37% |
EPS (Basic) | 61.00 | -135.00 | 911.50 | 988.20 | 1002.06 |
EPS (Diluted) | 61.00 | -135.00 | 911.50 | 988.00 | 1002.00 |
EPS Growth | - | - | -7.74% | -1.40% | 41.33% |
Free Cash Flow | 3,956 | 9,120 | 3,996 | 5,589 | 10,048 |
Free Cash Flow Per Share | 318.46 | 684.93 | 291.70 | 397.32 | 703.01 |
Gross Margin | 38.19% | 36.74% | 38.15% | 42.50% | 41.54% |
Operating Margin | -0.22% | 6.08% | 13.03% | 18.06% | 20.15% |
Profit Margin | 0.70% | -1.68% | 12.75% | 16.83% | 19.28% |
Free Cash Flow Margin | 3.66% | 8.53% | 4.08% | 6.77% | 13.53% |
EBITDA | 8,249 | 13,763 | 17,035 | 18,551 | 18,529 |
EBITDA Margin | 7.63% | 12.86% | 17.40% | 22.46% | 24.94% |
D&A For EBITDA | 8,493 | 7,254 | 4,278 | 3,633 | 3,561 |
EBIT | -243.29 | 6,509 | 12,757 | 14,918 | 14,968 |
EBIT Margin | -0.22% | 6.08% | 13.03% | 18.06% | 20.15% |
Effective Tax Rate | - | - | 4.67% | 11.49% | 9.28% |
Advertising Expenses | 1,793 | 1,180 | 1,299 | 588.44 | 449.68 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.